Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Apr 7, 2016
Debt, Debt and More Debt
Image Source: Michael Fleshman. A shocking statistic in education, an important “hidden” data point on auto sales, trouble at the malls, tracking the commercial aerospace cycle, and our thesis on banking equities continues to ring true... Apr 7, 2016
Shares Are Pricey, Initiating Coverage of Kraft Heinz
Image Source: Kraft-Heinz. "On an asset base of more than $120 billion, Kraft Heinz generated a total profit to shareholders of just $2.46 billion in 2014 and 2015 combined. Though adjusted EBITDA marks came in much better, the company is not making the best use of its asset base, which includes a goodwill and intangible balance of over $100 billion. Shares trade at a substantial premium to peers." -- Valuentum Securities Apr 4, 2016
GE Pulls Back From 8-Year High, Russia Still Pumping
Let’s get the week of April 4 started off right. Apr 4, 2016
Don’t Be Tempted By Homebuilders’ Dividends
Image Source: Toll Brothers. "We wanted to get our thoughts out to you as soon as possible in case you get talked into buying a homebuilder’s equity for income purposes a full seven years after the March 2009 panic bottom in the S&P 500." -- Valuentum Securities Mar 24, 2016
Initiating Coverage of PayPal with $50 Fair Value Estimate
Image Source: PayPal. We think PayPal has one of the strongest business models. Its strong net cash-rich balance sheet and tremendous free cash flow generation make for a compelling idea. Mar 23, 2016
Part II: Nelson’s Evaluation of Berkshire’s 2015 Annual Report
Image source: /\ \/\/ /\. The second of Nelson’s three-part evaluation of Berkshire Hathaway’s 2015 annual report. Mar 21, 2016
Crude Oil Prices Now Near $40 Per Barrel
Image: Top holdings of the Energy Select Sector SPDR; source: State Street.How we’re “playing” the dead-cat bounce in energy… Mar 15, 2016
Valeant’s Back Firmly Up Against the Wall
Image: A bottle of Valeant's anti-depression drug Wellbrutin lay in disarray, much like the company's operations. Wellbrutin was one of several key drugs on which Valeant used questionable pricing strategies to increase sales, source: Wendy. Valeant shares have been punished by the market for a combination of poor performance, a weak outlook, legal, political and financial trouble, and the warning of the potential for default. Mar 14, 2016
The Corporate Buyback Conundrum
The broader risks to the market remain, and the biggest buyer of stock is not who you think. Are corporations the ones holding this market together? Mar 12, 2016
Big Labor Topples Republic Airways; More Trouble for Other Airlines?
Image Source: Boeing. Big Labor is growing stronger as the commercial airline cycle matures, and a looming pilot shortage may once again squeeze economic profits across the airline industry in coming years. Republic Airways’ bankruptcy filing is the latest reminder why we steer clear of airline stocks in the newsletter portfolios.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202203204205206207208209210211212213214215216217218219220 221222223224225226227228229230231232233234235236237238239240 241242243244245246247248249250251252253254255256257258259260 261262263264265266267next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|